<PAGE>
                    
                    
                       U.S. SECURITIES AND EXCHANGE COMMISSION
                    
                              WASHINGTON, D.C. 20549
                    
                                    FORM 10-Q/A
                                           
                    QUARTERLY REPORT PURSUANT TO SECTION 13 OR
                   15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
                   FOR THE QUARTERLY PERIOD ENDED SEPT. 30, 1997
   

                              XANTHIC ENTERPRISES, INC.

                             
                          COMMISSION FILE NO. 33-17966-LA
                                
              A Colorado Corporation           EIN: 94-3030021
                                
                        8833 Sunset Blvd. Suite 200
                          West Hollywood, CA 90069
                                
                           Telephone: 310-289-4947
                                
          Securities registered under Section 12(g) of the Exchange Act:
                                
            Common Shares and Series A and Series B
                 Common Stock Purchase Warrants
                              
                                         
          
            The registrant has filed all reports
            required to be filed by Section 13 or 15(d)
            of the Exchange Act during the past 12 months
            or such shorter period for which such reports
            were required. The Company's Form 10-K for
            the fiscal year ended December 31, 1996 was
            filed late. 
                   
            The number of common shares issued and
            outstanding as of December 31, 1996 was
            5,481,826.
            <PAGE>
                    
                                     
                                           SIGNATURE
                    
                           In accordance with Section 13 or
                    15(d) of the Securities Exchange Act of
                    1934, this registrant caused this report to
                    be signed on its behalf by the undersigned,
                    thereunto duly authorized.
                    
                    
                    XANTHIC ENTERPRISES, INC.
                    
                    
                    Dated:        01/22/98        
                                  -------             
                    
                    
                    
                        By:   /s/ Mark A. Lilly
                              ---------------------------------         
                              Mark A. Lilly, President, Director
                              and Chief Financial Officer
                    
                    
                    
[TYPE]              EX-27
[DESCRIPTION]       ART 5 FINANCIAL DATA SCHEDULE
                    FOR THIRD QUARTER 1997 10-Q

[LEGEND]     THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION      
EXTRACTED FROM THE CORPORATIONS FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER
30, 1997, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL 
STATEMENTS.

[MULTIPLIER]                              0
[S]                    [C]
[PERIOD-TYPE]                             3 MOS
[FISCAL-YEAR-END]                         DEC-31-1996
[PERIOD-END]                              SEP-30-1997
[CASH]                                    0
[SECURITIES]                              0
[RECEIVABLES]                             0
[ALLOWANCES]                              0
[INVENTORY]                               0
<CURRENT ASSETS>                          0
[PP&E]                                    0
[DEPRECIATION]                            0
<TOTAL ASSETS>                            0
<CURRENT LIABILITIES>                     77,368
[BONDS]                                   0
[PREFERRED-MANDATORY]                     0
[PREFERRED]                               0
[COMMON]                                  5,481,826
<OTHER SE>                                0
[TOTAL-LIABILITY-AND-EQUITY]              (77,368)
[SALES]                                   0
<TOTAL REVENUES>                          0
[CGS]                                     0
<TOTAL COSTS>                             (63,509)
<OTHER EXPENSES>                          0
<LOSS PROVISION>                          0
<INTEREST EXPENSE>                        ()
<INCOME PRETAX>
[INCOME-TAX]                              0
<INCOME CONTINUING>                       0
[DISCONTINUED]                            0
[EXTRAORDINARY]                           0
[CHANGES]                                 0
<NET INCOME>                              0
[EPS-PRIMARY]                             0
[EPS-DILUTED]                             0